This report aims to provide a comprehensive presentation of the global market for Ankylosing Spondylitis, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ankylosing Spondylitis.

The Ankylosing Spondylitis market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Ankylosing Spondylitis market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ankylosing Spondylitis manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Ankylosing Spondylitis market size in 2022 is 5274.80 million US dollars, and it is expected to be 9331.12 million US dollars by 2029, with a compound annual growth rate of 8.49% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Ankylosing Spondylitis market include AbbVie, Inc., Pfizer, Inc., Novartis AG, Amgen, Inc., and Johnson & Johnson. The share of the top 3 players in the Ankylosing Spondylitis market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Ankylosing Spondylitis market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Painkillers and non-steroidal anti-inflammatory drugs (NSAIDs) accounted for XX% of Ankylosing Spondylitis market in 2022. Disease-modifying anti-rheumatic drugs (DMARDs) share of XX%.
Hospitals accounted for XX% of the Ankylosing Spondylitis market in 2022. Clinics accounts for XX%.

Highlights-Regions

Americas
United States
Canada
Brazil
Argentina
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
MEA
Saudi Arabia
UAE
Turkey

Player list
AbbVie, Inc.
Pfizer, Inc.
Novartis AG
Amgen, Inc.
Johnson & Johnson
Eli Lilly and Company
UCB, Inc.
Merck & Co., Inc

Types list
Painkillers and non-steroidal anti-inflammatory drugs (NSAIDs)
Disease-modifying anti-rheumatic drugs (DMARDs)
Biological therapies
Steroids
Physical therapies
Surgery

Application list
Hospitals
Clinics
Others

Table of Content

1 Study Coverage
1.1 Ankylosing Spondylitis Product Introduction
1.2 Market by Type
1.2.1 Global Ankylosing Spondylitis Market Size Growth Rate by Type, 2018 VS 2023 VS 2029
1.3 Market by Application
1.3.1 Global Ankylosing Spondylitis Market Size Growth Rate by Application, 2018 VS 2023 VS 2029
1.4 Global Ankylosing Spondylitis Market by Region
1.4.1 Global Ankylosing Spondylitis Market by Region: 2018 VS 2023 VS 2029
1.4.2 Global Ankylosing Spondylitis Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Ankylosing Spondylitis Revenue by Players
2.1.1 Global Ankylosing Spondylitis Revenue by Players (2018-2023)
2.1.2 Global Ankylosing Spondylitis Revenue Market Share by Players (2018-2023)
2.1.3 Global Top 5 and Top 10 Companies by Ankylosing Spondylitis Revenue in 2023
2.2 Global Ankylosing Spondylitis Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Ankylosing Spondylitis Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 AbbVie, Inc.
3.1.1 AbbVie, Inc. Information
3.1.2 AbbVie, Inc. Overview
3.1.3 AbbVie, Inc. Ankylosing Spondylitis Revenue and Gross Margin (2018-2023)
3.1.4 AbbVie, Inc. Related Developments
3.2 Pfizer, Inc.
3.2.1 Pfizer, Inc. Information
3.2.2 Pfizer, Inc. Overview
3.2.3 Pfizer, Inc. Ankylosing Spondylitis Revenue and Gross Margin (2018-2023)
3.2.4 Pfizer, Inc. Related Developments
3.3 Novartis AG
3.3.1 Novartis AG Information
3.3.2 Novartis AG Overview
3.3.3 Novartis AG Ankylosing Spondylitis Revenue and Gross Margin (2018-2023)
3.3.4 Novartis AG Related Developments
3.4 Amgen, Inc.
3.4.1 Amgen, Inc. Information
3.4.2 Amgen, Inc. Overview
3.4.3 Amgen, Inc. Ankylosing Spondylitis Revenue and Gross Margin (2018-2023)
3.4.4 Amgen, Inc. Related Developments
3.5 Johnson & Johnson
3.5.1 Johnson & Johnson Information
3.5.2 Johnson & Johnson Overview
3.5.3 Johnson & Johnson Ankylosing Spondylitis Revenue and Gross Margin (2018-2023)
3.5.4 Johnson & Johnson Related Developments
3.6 Eli Lilly and Company
3.6.1 Eli Lilly and Company Information
3.6.2 Eli Lilly and Company Overview
3.6.3 Eli Lilly and Company Ankylosing Spondylitis Revenue and Gross Margin (2018-2023)
3.6.4 Eli Lilly and Company Related Developments
3.7 UCB, Inc.
3.7.1 UCB, Inc. Information
3.7.2 UCB, Inc. Overview
3.7.3 UCB, Inc. Ankylosing Spondylitis Revenue and Gross Margin (2018-2023)
3.7.4 UCB, Inc. Related Developments
3.8 Merck & Co., Inc
3.8.1 Merck & Co., Inc Information
3.8.2 Merck & Co., Inc Overview
3.8.3 Merck & Co., Inc Ankylosing Spondylitis Revenue and Gross Margin (2018-2023)
3.8.4 Merck & Co., Inc Related Developments
4 Market Size by Type
4.1 Global Ankylosing Spondylitis Revenue by Type
4.2 Global Ankylosing Spondylitis Market Size Growth by Type 2018-2023
5 Market Size by Application
5.1 Global Ankylosing Spondylitis Revenue by Application
5.2 Global Ankylosing Spondylitis Market Size Growth by Application 2018-2023
6 Global Ankylosing Spondylitis Market Insights
6.1 Global Ankylosing Spondylitis Market Revenue 2018-2023
6.2 Global Ankylosing Spondylitis Revenue by Region
6.3 Americas
6.4 Europe
6.5 Asia-Pacific
6.6 Middle East & Africa
7 Americas
7.1 Americas Ankylosing Spondylitis Market Size by Country
7.1.1 Americas Ankylosing Spondylitis Revenue by Country (2018-2023)
7.1.2 U.S.
7.1.3 Canada
7.1.4 Mexico
7.1.5 Brazil
7.1.6 Argentina
8 Europe
8.1 Europe Ankylosing Spondylitis Market Size by Country
8.1.1 Europe Ankylosing Spondylitis Revenue by Country (2018-2023)
8.1.2 Germany
8.1.3 France
8.1.4 U.K.
8.1.5 Italy
8.1.6 Russia
9 Asia Pacific
9.1 Asia Pacific Ankylosing Spondylitis Market Size by Region
9.1.1 Asia Pacific Ankylosing Spondylitis Revenue by Region (2018-2023)
9.1.2 China
9.1.3 Japan
9.1.4 South Korea
9.1.5 India
9.1.6 Southeast Asia
9.1.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Ankylosing Spondylitis Market Size by Country
10.1.1 Middle East and Africa Ankylosing Spondylitis Revenue by Country (2018-2023)
10.1.2 Turkey
10.1.3 Saudi Arabia
10.1.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Ankylosing Spondylitis Industry Trends
11.2 Ankylosing Spondylitis Market Drivers
11.3 Ankylosing Spondylitis Market Challenges
11.4 Ankylosing Spondylitis Market Restraints
12 Ankylosing Spondylitis Forecasted Market Size by Type
12.1 Global Ankylosing Spondylitis Forecasted Revenue by Type
12.2 Global Ankylosing Spondylitis Forecasted Market Size Growth by Type 2023-2029
13 Ankylosing Spondylitis Forecasted Market Size by Application
13.1 Global Ankylosing Spondylitis Forecasted Revenue by Application
13.2 Global Ankylosing Spondylitis Forecasted Market Size Growth by Application 2023-2029
14 Global Ankylosing Spondylitis Market Forecasts
14.1 Global Ankylosing Spondylitis Market Revenue Forecasts 2023-2029
14.2 Global Ankylosing Spondylitis Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Ankylosing Spondylitis Forecasts Revenue by Country (2018-2023)
14.4 Europe
14.4.1 Europe Ankylosing Spondylitis Forecasts Revenue by Country (2018-2023)
14.5 Asia-Pacific
14.5.1 Asia Pacific Ankylosing Spondylitis Forecasts Revenue by Country (2018-2023)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Ankylosing Spondylitis Forecasts Revenue by Country (2018-2023)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer

List of Tables and Figures

Figure Ankylosing Spondylitis Picture
Table Product Definition of Ankylosing Spondylitis
Table Global Ankylosing Spondylitis Market Size Growth Rate by Type, 2018 VS 2023 VS 2029
Table Global Ankylosing Spondylitis Market Size Growth Rate by Application, 2018 VS 2023 VS 2029
Table Global Ankylosing Spondylitis Market by Region: 2018 VS 2023 VS 2029
Figure Global Ankylosing Spondylitis Revenue Market Size & Forecasts 2018-2029
Figure Years Considered
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Ankylosing Spondylitis Revenue by Players (2018-2023)
Table Global Ankylosing Spondylitis Revenue Market Share by Players (2018-2023)
Figure Top 5 Largest Players of Ankylosing Spondylitis in 2023
Figure Top 10 Largest Players of Ankylosing Spondylitis in 2023
Table Global Ankylosing Spondylitis Gross Margin by Players
Table Players Market Concentration Ratio (CR5)
Table Global Ankylosing Spondylitis Players Geographical Distribution
Table Mergers & Acquisitions, Expansion Plans
Table Company Profiles
Table AbbVie, Inc. Overview
Table AbbVie, Inc. Revenue, Gross, Gross Margin 2018-2023
Table AbbVie, Inc. Related Developments
Table Company Profiles
Table Pfizer, Inc. Overview
Table Pfizer, Inc. Revenue, Gross, Gross Margin 2018-2023
Table Pfizer, Inc. Related Developments
Table Company Profiles
Table Novartis AG Overview
Table Novartis AG Revenue, Gross, Gross Margin 2018-2023
Table Novartis AG Related Developments
Table Company Profiles
Table Amgen, Inc. Overview
Table Amgen, Inc. Revenue, Gross, Gross Margin 2018-2023
Table Amgen, Inc. Related Developments
Table Company Profiles
Table Johnson & Johnson Overview
Table Johnson & Johnson Revenue, Gross, Gross Margin 2018-2023
Table Johnson & Johnson Related Developments
Table Company Profiles
Table Eli Lilly and Company Overview
Table Eli Lilly and Company Revenue, Gross, Gross Margin 2018-2023
Table Eli Lilly and Company Related Developments
Table Company Profiles
Table UCB, Inc. Overview
Table UCB, Inc. Revenue, Gross, Gross Margin 2018-2023
Table UCB, Inc. Related Developments
Table Company Profiles
Table Merck & Co., Inc Overview
Table Merck & Co., Inc Revenue, Gross, Gross Margin 2018-2023
Table Merck & Co., Inc Related Developments
Table Global Ankylosing Spondylitis Revenue by Type (2018-2023)
Table Global Ankylosing Spondylitis Revenue Share by Type (2018-2023)
Table Global Ankylosing Spondylitis Revenue by Application (2018-2023)
Table Global Ankylosing Spondylitis Revenue Share by Application (2018-2023)
Figure Global Ankylosing Spondylitis Market Revenue 2018-2023
Table Global Ankylosing Spondylitis Revenue by Region (2018-2023)
Table Global Ankylosing Spondylitis Revenue Share by Region (2018-2023)
Figure Americas Ankylosing Spondylitis Revenue (2018-2023)
Figure Europe Ankylosing Spondylitis Revenue (2018-2023)
Figure Asia-Pacific Ankylosing Spondylitis Revenue (2018-2023)
Figure Middle East & Africa Ankylosing Spondylitis Revenue (2018-2023)
Table Americas Ankylosing Spondylitis Revenue by Country (2018-2023)
Table Americas Ankylosing Spondylitis Revenue Share by Country (2018-2023)
Figure United States Ankylosing Spondylitis Revenue Market Size (2018-2023)
Figure Canada Ankylosing Spondylitis Revenue Market Size (2018-2023)
Figure Mexico Ankylosing Spondylitis Revenue Market Size (2018-2023)
Figure Brazil Ankylosing Spondylitis Revenue Market Size (2018-2023)
Figure Argentina Ankylosing Spondylitis Revenue Market Size (2018-2023)
Table Europe Ankylosing Spondylitis Revenue by Country (2018-2023)
Table Europe Ankylosing Spondylitis Revenue Share by Country (2018-2023)
Figure Germany Ankylosing Spondylitis Revenue Market Size (2018-2023)
Figure France Ankylosing Spondylitis Revenue Market Size (2018-2023)
Figure U.K. Ankylosing Spondylitis Revenue Market Size (2018-2023)
Figure Italy Ankylosing Spondylitis Revenue Market Size (2018-2023)
Figure Russia Ankylosing Spondylitis Revenue Market Size (2018-2023)
Table Asia Pacific Ankylosing Spondylitis Revenue by Region (2018-2023)
Table Asia Pacific Ankylosing Spondylitis Revenue Share by Region (2018-2023)
Figure China Ankylosing Spondylitis Revenue Market Size (2018-2023)
Figure Japan Ankylosing Spondylitis Revenue Market Size (2018-2023)
Figure South Korea Ankylosing Spondylitis Revenue Market Size (2018-2023)
Figure India Ankylosing Spondylitis Revenue Market Size (2018-2023)
Figure Southeast Asia Ankylosing Spondylitis Revenue Market Size (2018-2023)
Figure Australia Ankylosing Spondylitis Revenue Market Size (2018-2023)
Table Middle East and Africa Ankylosing Spondylitis Revenue by Country (2018-2023)
Table Middle East and Africa Ankylosing Spondylitis Revenue Share by Country (2018-2023)
Figure Turkey Ankylosing Spondylitis Revenue Market Size (2018-2023)
Figure Saudi Arabia Ankylosing Spondylitis Revenue Market Size (2018-2023)
Figure U.A.E Ankylosing Spondylitis Revenue Market Size (2018-2023)
Table Global Ankylosing Spondylitis Forecasted Revenue by Type (2018-2023)
Table Global Ankylosing Spondylitis Forecasted Revenue Share by Type (2018-2023)
Table Global Ankylosing Spondylitis Forecasted Revenue by Application (2018-2023)
Table Global Ankylosing Spondylitis Forecasted Revenue Share by Application (2018-2023)
Figure Global Ankylosing Spondylitis Market Revenue Forecasts 2023-2029
Table Global Ankylosing Spondylitis Forecasts Revenue by Region (2023-2029)
Table Global Ankylosing Spondylitis Forecasts Revenue Share by Region (2023-2029)
Figure Americas Ankylosing Spondylitis Forecasts Revenue and Growth (2023-2029)
Table Americas Ankylosing Spondylitis Forecasts Revenue by Country (2018-2023)
Table Americas Ankylosing Spondylitis Forecasts Revenue Share by Country (2018-2023)
Figure Europe Ankylosing Spondylitis Forecasts Revenue and Growth (2023-2029)
Table Europe Ankylosing Spondylitis Forecasts Revenue by Country (2018-2023)
Table Europe Ankylosing Spondylitis Forecasts Revenue Share by Country (2018-2023)
Figure Asia-Pacific Ankylosing Spondylitis Forecasts Revenue and Growth (2023-2029)
Table Asia Pacific Ankylosing Spondylitis Forecasts Revenue by Country (2018-2023)
Table Asia Pacific Ankylosing Spondylitis Forecasts Revenue Share by Country (2018-2023)
Figure Middle East & Africa Ankylosing Spondylitis Forecasts Revenue and Growth (2023-2029)
Table Middle East and Africa Ankylosing Spondylitis Forecasts Revenue by Country (2018-2023)
Table Middle East and Africa Ankylosing Spondylitis Forecasts Revenue Share by Country (2018-2023)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report